AP
Aida Pharmaceuticals Inc Stock: price and insider trades · United States
US·Mcap US$12.6M
No insider purchase over the last 90 days. The latest, by JIN BAIO, was filed 12 Mar 2007.
Aida Pharmaceuticals Inc: what insiders have been doing
This page follows insider dealings at Aida Pharmaceuticals Inc as filed with SEC (Form 4). No insider at Aida Pharmaceuticals Inc has published a filing in the past twelve months. The most recent one dates from 12 March 2007.
The full history, which starts in 2007, counts 2 purchases against 1 sale.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€4,547
2 ops. · all time
Sell Volume
€1,221
1 ops. · all time
Financial data
· cache
US$0.00
Analyst consensus
Income statement
EBITDAUS$9.5M
Valuation
P/Book0.0x
Beta23.33
Balance sheet & cash
Market capUS$12.6M
Debt / Equity237%
Profitability & ownership
ROE-1.8%
ROA6.6%
Last declaration on 12 March 2007
Declarations3 total
- 5,343,525 shares@ US$0.001Common StockSEC:0001078782-07-000215:0Canonical exit: 19 Mar 2007 (T+90)
- 1,611,939 shares@ US$0.001Common StockSEC:0001078782-07-000211:0
- 661,512 shares@ US$0.001Common StockSEC:0001078782-07-000214:0Canonical exit: 19 Mar 2007 (T+90)
3 of 3 declarations
About Aida Pharmaceuticals Inc
Aida Pharmaceuticals Inc is a company focused on the development and marketing of pharmaceutical products. It is listed on NASDAQ under the symbol XNAS.
